Analyst consensus rating
PMV Pharmaceuticals Analyst Rating: Strong Buy
PMVP is rated Strong Buy by 4 analysts with a $4.00 target. As of 2026-09-02.
Direct answer
PMV Pharmaceuticals's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked September 2, 2026.
Get free PMV Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.26
- Average price target
- $4.00
- High price target
- $5.00
- Low price target
- $3.00
- Low target gap
- +139%
- Target upside
- +218.7%
- High target gap
- +298.4%
- Target range width
- 159.4%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for PMV Pharmaceuticals?
PMV Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $4.00.
How far are PMV Pharmaceuticals's low and high targets from the recorded price?
The low target implies +139%, while the high target implies +298.4%.
How many analysts are included in PMV Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is PMV Pharmaceuticals's target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $1.26, then one is subtracted to produce +218.7%. This does not guarantee a future return.
When was PMV Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.